Utah Medical Products (UTMD)
Utah Medical Products Revenue Growth: 64.96%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
UTMD Revenue Growth Rankings
| Overall | 94th percentile | 244 of 4363 |
| Sector | 87th percentile | 56 of 457 in Healthcare |
| Industry | 90th percentile | 6 of 65 in Medical Instruments & Supplies |
UTMD Revenue Growth Range, Past 5 Years
| Minimum | -11.38% | Jun 2009 |
| Maximum | 73.91% | Sep 2011 |
| Average | 10.86% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these UTMD related companies
UTMD News
Utah Medical Products, Inc. (UTMD) Declares $0.24 Quarterly Dividend; 3% Yield
May 08, 10:28AM Street Insider
May 08, 10:28AM Street Insider
Utah Medical Products (UTMD) Reports Q1 Earnings of $0.76; Boosts FY12 EPS Range by 5c
Apr 25, 9:06AM Street Insider
Apr 25, 9:06AM Street Insider
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2012
Apr 25, 9:00AM GlobeNewswire
Apr 25, 9:00AM GlobeNewswire
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DHN
about 58 days ago by MarketBrief
about 58 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3C9K
about 59 days ago by MarketBrief
about 59 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3AqU
about 60 days ago by MarketBrief
about 60 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/39IJ
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/383m
about 64 days ago by MarketBrief
about 64 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/36qW
about 65 days ago by MarketBrief
about 65 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/35fy
about 66 days ago by MarketBrief
about 66 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/347o
about 67 days ago by MarketBrief
about 67 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/32g3
about 70 days ago by MarketBrief
about 70 days ago by MarketBrief
Utah Medical Products, Inc. (UTMD) Declares $0.24 Quarterly Dividend; 3.3% Yield
Feb 07, 10:01AM Street Insider
Feb 07, 10:01AM Street Insider
Utah Medical Products, Inc. Reports Financial Performance for Fourth Quarter and Year 2011
Jan 31, 9:00AM GlobeNewswire
Jan 31, 9:00AM GlobeNewswire
Utah Medical Products, Inc. (UTMD) Raises Quarterly Dividend 2% to $0.24; 3.7% Yield
Nov 01, 10:01AM Street Insider
Nov 01, 10:01AM Street Insider
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2011
Oct 20, 9:00AM GlobeNewswire
Oct 20, 9:00AM GlobeNewswire
We highlighted $UTMD yesterday and it finished up 3.92%, not bad in today's tape.
about 1060 days ago by MOFinancial
about 1060 days ago by MOFinancial
Good dividend, great balance sheet, $UTMD...has been hot lately, don't know if it's safe here...but if you get a pullback, I'm a buyer.
about 1060 days ago by MOFinancial
about 1060 days ago by MOFinancial
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| UTMD | 34.10 | +3.30 | +10.71% | 124.81M |
| UTL | 26.61 | +0.35 | +1.33% | 292.18M |
| UTIW | 15.64 | -0.02 | -0.13% | 1.608B |
| UTI | 12.19 | +0.14 | +1.16% | 301.21M |
| UTHR | 44.24 | -0.48 | -1.07% | 2.373B |
| UNL | 16.31 | +0.09 | +0.55% | |
| UNIS | 4.17 | +0.17 | +4.25% | 308.00M |
| UNH | 55.77 | -0.40 | -0.71% | 58.28B |
| UNG | 16.79 | -0.12 | -0.71% | |
| UNFI | 50.70 | -0.11 | -0.22% | 2.472B |
